Global POC Molecular Diagnostics Market 2017-2021

POC分子診断の世界市場2017-2021

◆タイトル:Global POC Molecular Diagnostics Market 2017-2021
◆商品コード:IRTNTR15199
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年11月16日
◆ページ数:113
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

Technavio社が発行した当調査レポートでは、POC分子診断の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、POC分子診断の世界市場規模及び予測、用途別分析、技術別分析、需要先別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。Technavio社はPOC分子診断の世界市場が2017-2021年期間中に年平均12.83%成長すると予測しています。当レポート上に記載されている主な企業は、Abbott、bioMérieux、Danaher、F. Hoffmann-La Roche等です。

About POC Molecular Diagnostics
POC molecular diagnostics help in identification, treatment, and prevention of infectious diseases, oncology, hematology, and prenatal diseases. The demand for POC molecular diagnostic products is increasing owing to the highly developed technologies, which are used to detect and amplify deoxyribonucleic acid (DNA)/RNA. The major factor driving the growth of this market is the increasing prevalence of pandemic diseases such as Ebola and Zika. Based on the reports by the Centers for Disease Control and Prevention (CDC) in March 2016, in Guinea and Liberia (Africa), 13 cases of Ebola were reported whereas more than 1,200 population came into contact with the virus.

Technavio’s analysts forecast the global POC molecular diagnostics market to grow at a CAGR of 12.83% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global POC molecular diagnostics market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global POC Molecular Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Abbott
• bioMérieux
• Danaher
• F. Hoffmann-La Roche

[Other prominent vendors]
• Agilent Technologies
• Akonni Biosystems
• altona Diagnostics
• Atlas Genetics
• BD
• Bionano Genomics
• BJS Biotechnologies
• Certest Biotec
• Co-Diagnostics
• Devyser
• Diagenode
• DiaSorin
• ExcitePCR
• genedrive
• GenePOC
• iCubate
• Illumina
• Merck
• Meridian Bioscience
• Mesa Biotech
• Micronics
• Nanobiosym
• NeoGenomics
• Nimagen
• Novigenix
• OraSure Technologies
• Oxford Nanopore Technologies
• PathoQuest
• PierianDx
• Precision System Science
• QuantuMDx
• Randox Laboratories
• SCIENION
• Seegene
• SpeeDX
• Sysmex
• Xagenic

[Market driver]
• Increased companies’ participation in conferences to showcase their products
• For a full, detailed list, view our report

[Market challenge]
• Low adoption among healthcare providers
• For a full, detailed list, view our report

[Market trend]
• Growing focus on next-generation products
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION
• Market outline

PART 05: MARKET LANDSCAPE
• Market size and forecast
• Five forces analysis

PART 06: MARKET SEGMENTATION BY APPLICATION
• Infectious diseases
• Oncology
• Hematology and endocrinology
• Others (prenatal and cardiac)

PART 07: MARKET SEGMENTATION BY TECHNOLOGY
• PCR (gene sequencing)
• Microarray and hybridization

PART 08: MARKET SEGMENTATION BY END-USER
• Market overview
• Hospital and clinics
• Diagnostic laboratories
• Research institutes

PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• POC molecular diagnostics market in Americas
• POC molecular diagnostics market in EMEA
• POC molecular diagnostics market in APAC
• Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 12: MARKET TRENDS
• Growing focus on next-generation products
• Liquid biopsy as an emerging trend
• Paradigm shift toward miRNAs

PART 13: VENDOR LANDSCAPE
• Competitive landscape

PART 14: KEY VENDOR ANALYSIS
• Abbott
• bioMérieux
• Danaher
• F. Hoffmann-La Roche
• Key companies to watch
• Other prominent vendors

PART 15: APPENDIX
• List of abbreviations

[List of Exhibits]
Exhibit 01: Difference between POC molecular diagnostic test and conventional testing process
Exhibit 02: Market overview: Global POC molecular diagnostics market 2017-2021
Exhibit 03: Global POC molecular diagnostics market 2016-2021 ($ millions)
Exhibit 04: Five forces analysis
Exhibit 05: Market share: Global POC molecular diagnostics market by application 2016
Exhibit 06: Market overview: Global POC molecular diagnostics market by infectious diseases
Exhibit 07: Market overview: Global POC molecular diagnostics market by oncology
Exhibit 08: Market share: Global POC molecular diagnostics market by technology
Exhibit 09: Market outlook of PCR (gene sequencing)
Exhibit 10: Overview of global POC molecular diagnostics market by PCR (gene sequencing)
Exhibit 11: Global POC molecular diagnostics market by PCR (gene sequencing) 2016-2021 ($ millions)
Exhibit 12: Overview of global POC molecular diagnostics market by microarray and hybridization
Exhibit 13: Global POC molecular diagnostics market by microarray and hybridization 2016-2021 ($ millions)
Exhibit 14: Global POC molecular diagnostics market by end-users: Strategic analysis 2016
Exhibit 15: Global POC molecular diagnostics market by geography 2016-2021 (%)
Exhibit 16: Regional comparison
Exhibit 17: POC molecular diagnostics market in Americas 2016-2021 ($ millions)
Exhibit 18: POC molecular diagnostics market in Americas: Year-over-year growth 2017-2021 (%)
Exhibit 19: Top 3 countries in Americas
Exhibit 20: POC molecular diagnostics market in EMEA 2016-2021 ($ millions)
Exhibit 21: POC molecular diagnostics market in EMEA: Year-over-year growth 2017-2021 (%)
Exhibit 22: Top 3 countries in EMEA
Exhibit 23: POC molecular diagnostics market in APAC 2016-2021 ($ millions)
Exhibit 24: POC molecular diagnostics market in APAC: Year-over-year growth 2017-2021 (%)
Exhibit 25: Top 3 countries in APAC
Exhibit 26: Competitive structure analysis of global POC molecular diagnostics market 2016
Exhibit 27: Strategic factors of companies in global POC molecular diagnostics market 2016
Exhibit 28: Abbott: Key highlights
Exhibit 29: Abbott: Strength assessment
Exhibit 30: Abbott: Strategy assessment
Exhibit 31: Abbott: Opportunity assessment
Exhibit 32: bioMérieux: Key highlights
Exhibit 33: bioMérieux: Strength assessment
Exhibit 34: bioMérieux: Strategy assessment
Exhibit 35: bioMérieux: Opportunity assessment
Exhibit 36: Danaher: Key highlights
Exhibit 37: Danaher: Strength assessment
Exhibit 38: Danaher: Strategy assessment
Exhibit 39: Danaher: Opportunity assessment
Exhibit 40: F. Hoffmann-La Roche: Key highlights
Exhibit 41: F. Hoffmann-La Roche: Strength assessment
Exhibit 42: F. Hoffmann-La Roche: Strategy assessment
Exhibit 43: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 44: Bio-Rad Laboratories: Company assessment
Exhibit 45: QIAGEN: Company assessment
Exhibit 46: Quidel: Company assessment
Exhibit 47: Thermo Fisher Scientific: Company assessment



【掲載企業】

Abbott, bioMérieux, Danaher, F. Hoffmann-La Roche, Agilent Technologies, Akonni Biosystems, altona Diagnostics, Atlas Genetics, BD, Bionano Genomics, BJS Biotechnologies, Certest Biotec, Co-Diagnostics, Devyser, Diagenode, DiaSorin, ExcitePCR, genedrive, GenePOC, iCubate, Illumina, Merck, Meridian Bioscience, Mesa Biotech, Micronics, Nanobiosym, NeoGenomics, Nimagen, Novigenix, OraSure Technologies, Oxford Nanopore Technologies, PathoQuest, PierianDx, Precision System Science, QuantuMDx, Randox Laboratories, SCIENION, Seegene, SpeeDX, Sysmex, and Xagenic.


【資料のキーワード】

POC分子診断

★調査レポート[POC分子診断の世界市場2017-2021] (Global POC Molecular Diagnostics Market 2017-2021 / IRTNTR15199)販売に関する免責事項
[POC分子診断の世界市場2017-2021] (Global POC Molecular Diagnostics Market 2017-2021 / IRTNTR15199)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆